Preferential hematopoiesis by paroxysmal nocturnal hemoglobinuria clone engrafted in SCID mice

Norihiro Iwamoto, Tatsuya Kawaguchi, Kentaro Horikawa, Shoichi Nagakura, Tadashi Kagimoto, Toshio Suda, Kiyoshi Takatsuki, Hideki Nakakuma

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

In paroxysmal nocturnal hemoglobinuria (PNH), little is known about the molecular events leading to the clinical manifestations except for the hemolysis. To unfold the complex pathophysiology, it is necessary to elucidate the nature of the PNH clone. PNH exhibits an acquired stem cell disorder, a clonal expansion of affected cells, concomitant depression of normal hematopoiesis in bone marrow (BM), and, although infrequently, the development of leukemia. The PNH clone is thus expected to exhibit some neoplastic features. We report here that CD34+ hematopoietic progenitor cells of PNH-BM yielded blood cells of three lineages with PNH phenotype alone when transplanted into sublethally irradiated severe combined immunedeficient mice. The hematopoiesis persisted for more than 10 months and did not always need human cytokines. In contrast, the hematopoiesis by control grafts obtained from healthy volunteers required an intense cytokine treatment. This in vivo model defines the preferential hematopoiesis of pluripotent PNH progenitor cells, indicating the intrinsic growth abnormality of PNH clone.

Original languageEnglish
Pages (from-to)4944-4948
Number of pages5
JournalBlood
Volume87
Issue number12
Publication statusPublished - 1996 Jun 15

Fingerprint

Paroxysmal Hemoglobinuria
SCID Mice
Hematopoiesis
Bone
Clone Cells
Cytokines
Stem cells
Grafts
Blood
Cells
Stem Cells
Bone Marrow
Cell Lineage
Hematopoietic Stem Cells
Hemolysis
Blood Cells
Healthy Volunteers
Leukemia
Transplants
Phenotype

ASJC Scopus subject areas

  • Hematology

Cite this

Iwamoto, N., Kawaguchi, T., Horikawa, K., Nagakura, S., Kagimoto, T., Suda, T., ... Nakakuma, H. (1996). Preferential hematopoiesis by paroxysmal nocturnal hemoglobinuria clone engrafted in SCID mice. Blood, 87(12), 4944-4948.

Preferential hematopoiesis by paroxysmal nocturnal hemoglobinuria clone engrafted in SCID mice. / Iwamoto, Norihiro; Kawaguchi, Tatsuya; Horikawa, Kentaro; Nagakura, Shoichi; Kagimoto, Tadashi; Suda, Toshio; Takatsuki, Kiyoshi; Nakakuma, Hideki.

In: Blood, Vol. 87, No. 12, 15.06.1996, p. 4944-4948.

Research output: Contribution to journalArticle

Iwamoto, N, Kawaguchi, T, Horikawa, K, Nagakura, S, Kagimoto, T, Suda, T, Takatsuki, K & Nakakuma, H 1996, 'Preferential hematopoiesis by paroxysmal nocturnal hemoglobinuria clone engrafted in SCID mice', Blood, vol. 87, no. 12, pp. 4944-4948.
Iwamoto N, Kawaguchi T, Horikawa K, Nagakura S, Kagimoto T, Suda T et al. Preferential hematopoiesis by paroxysmal nocturnal hemoglobinuria clone engrafted in SCID mice. Blood. 1996 Jun 15;87(12):4944-4948.
Iwamoto, Norihiro ; Kawaguchi, Tatsuya ; Horikawa, Kentaro ; Nagakura, Shoichi ; Kagimoto, Tadashi ; Suda, Toshio ; Takatsuki, Kiyoshi ; Nakakuma, Hideki. / Preferential hematopoiesis by paroxysmal nocturnal hemoglobinuria clone engrafted in SCID mice. In: Blood. 1996 ; Vol. 87, No. 12. pp. 4944-4948.
@article{2247efbf1b9044698a2d09b14b1c1c2a,
title = "Preferential hematopoiesis by paroxysmal nocturnal hemoglobinuria clone engrafted in SCID mice",
abstract = "In paroxysmal nocturnal hemoglobinuria (PNH), little is known about the molecular events leading to the clinical manifestations except for the hemolysis. To unfold the complex pathophysiology, it is necessary to elucidate the nature of the PNH clone. PNH exhibits an acquired stem cell disorder, a clonal expansion of affected cells, concomitant depression of normal hematopoiesis in bone marrow (BM), and, although infrequently, the development of leukemia. The PNH clone is thus expected to exhibit some neoplastic features. We report here that CD34+ hematopoietic progenitor cells of PNH-BM yielded blood cells of three lineages with PNH phenotype alone when transplanted into sublethally irradiated severe combined immunedeficient mice. The hematopoiesis persisted for more than 10 months and did not always need human cytokines. In contrast, the hematopoiesis by control grafts obtained from healthy volunteers required an intense cytokine treatment. This in vivo model defines the preferential hematopoiesis of pluripotent PNH progenitor cells, indicating the intrinsic growth abnormality of PNH clone.",
author = "Norihiro Iwamoto and Tatsuya Kawaguchi and Kentaro Horikawa and Shoichi Nagakura and Tadashi Kagimoto and Toshio Suda and Kiyoshi Takatsuki and Hideki Nakakuma",
year = "1996",
month = "6",
day = "15",
language = "English",
volume = "87",
pages = "4944--4948",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "12",

}

TY - JOUR

T1 - Preferential hematopoiesis by paroxysmal nocturnal hemoglobinuria clone engrafted in SCID mice

AU - Iwamoto, Norihiro

AU - Kawaguchi, Tatsuya

AU - Horikawa, Kentaro

AU - Nagakura, Shoichi

AU - Kagimoto, Tadashi

AU - Suda, Toshio

AU - Takatsuki, Kiyoshi

AU - Nakakuma, Hideki

PY - 1996/6/15

Y1 - 1996/6/15

N2 - In paroxysmal nocturnal hemoglobinuria (PNH), little is known about the molecular events leading to the clinical manifestations except for the hemolysis. To unfold the complex pathophysiology, it is necessary to elucidate the nature of the PNH clone. PNH exhibits an acquired stem cell disorder, a clonal expansion of affected cells, concomitant depression of normal hematopoiesis in bone marrow (BM), and, although infrequently, the development of leukemia. The PNH clone is thus expected to exhibit some neoplastic features. We report here that CD34+ hematopoietic progenitor cells of PNH-BM yielded blood cells of three lineages with PNH phenotype alone when transplanted into sublethally irradiated severe combined immunedeficient mice. The hematopoiesis persisted for more than 10 months and did not always need human cytokines. In contrast, the hematopoiesis by control grafts obtained from healthy volunteers required an intense cytokine treatment. This in vivo model defines the preferential hematopoiesis of pluripotent PNH progenitor cells, indicating the intrinsic growth abnormality of PNH clone.

AB - In paroxysmal nocturnal hemoglobinuria (PNH), little is known about the molecular events leading to the clinical manifestations except for the hemolysis. To unfold the complex pathophysiology, it is necessary to elucidate the nature of the PNH clone. PNH exhibits an acquired stem cell disorder, a clonal expansion of affected cells, concomitant depression of normal hematopoiesis in bone marrow (BM), and, although infrequently, the development of leukemia. The PNH clone is thus expected to exhibit some neoplastic features. We report here that CD34+ hematopoietic progenitor cells of PNH-BM yielded blood cells of three lineages with PNH phenotype alone when transplanted into sublethally irradiated severe combined immunedeficient mice. The hematopoiesis persisted for more than 10 months and did not always need human cytokines. In contrast, the hematopoiesis by control grafts obtained from healthy volunteers required an intense cytokine treatment. This in vivo model defines the preferential hematopoiesis of pluripotent PNH progenitor cells, indicating the intrinsic growth abnormality of PNH clone.

UR - http://www.scopus.com/inward/record.url?scp=0029895043&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029895043&partnerID=8YFLogxK

M3 - Article

VL - 87

SP - 4944

EP - 4948

JO - Blood

JF - Blood

SN - 0006-4971

IS - 12

ER -